irsogladine has been researched along with Angiogenesis, Pathologic in 5 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sato, Y | 2 |
Morimoto, A | 1 |
Kiue, A | 1 |
Okamura, K | 1 |
Hamanaka, R | 1 |
Kohno, K | 1 |
Kuwano, M | 4 |
Sakata, T | 1 |
Ono, M | 3 |
Kawahara, N | 1 |
Goto, D | 1 |
Wakabayashi, Y | 1 |
Ushiro, S | 1 |
Yoshida, S | 1 |
Izumi, H | 1 |
Ren, CJ | 1 |
Ueda, F | 1 |
Roses, DF | 1 |
Harris, MN | 1 |
Mignatti, P | 1 |
Rifkin, DB | 1 |
Shapiro, RL | 1 |
2 reviews available for irsogladine and Angiogenesis, Pathologic
Article | Year |
---|---|
[Development of anti tumor agents targeting angiogenesis].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanes; Drug Screening Assays, Antitumor; Enz | 1997 |
[Angiogenesis and its inhibitors].
Topics: Animals; Antineoplastic Agents; Collagen; Endostatins; Endothelium, Vascular; Growth Inhibitors; Hum | 1997 |
3 other studies available for irsogladine and Angiogenesis, Pathologic
Article | Year |
---|---|
Irsogladine is a potent inhibitor of angiogenesis.
Topics: Animals; Cells, Cultured; Endothelium, Vascular; Enzyme Induction; Humans; Mice; Neovascularization, | 1993 |
Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine.
Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents; Cell Line; Humans; Male; Mice; Mice, Inbred BALB | 1996 |
Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice.
Topics: Animals; Antineoplastic Agents; Cornea; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2 | 1998 |